Communications
1987; Wiley; Volume: 91; Issue: S1 Linguagem: Francês
10.1111/j.1476-5381.1987.tb16271.x
ISSN1476-5381
Tópico(s)Neuropeptides and Animal Physiology
ResumoBritish Journal of PharmacologyVolume 91, Issue S1 p. 293P-510P Free Access Communications First published: June 1987 https://doi.org/10.1111/j.1476-5381.1987.tb16271.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Hodgson, HJF, Potter, BJ, Skinner, J. & Jewell, DP (1978) Gut, 19, 225– 232. Juan, H. & Lembeck, F. (1974) Naunyn-Schmiedebergs Arch. Pharmac. 283, 151– 164. Lembeck, F., Popper, H. & Juan, H. (1976) Naunyn-Schmiedebergs Arch. Pharmac. 294, 69– 73. Vavrek, R.J. & Stewart, J.M. (1985) Peptides 6, 161– 164. Nustad, K., Vaaje, K. (1975). Synthesis of kallikrein by rat kidney slices. Br. J. Pharmac. 53, 229– 234. Lauar, N., Shacklady, M., Bhoola, K.D. (1982). Factors influencing the in vitro release of renal kallikrein. Agents & Actions 9 (Suppl.), pp. 545– 552. W.W.Y. Lo Is a Commonwealth Scholar and a Bye-Fellow of Downing College, Cambridge. HENDERSON, G., HUGHES, J. & KOSTERLITZ, H.W. (1972) Br.J.Pharmac. 46, 764– 766. HENDERSON, G. & ROGERS, H. (1987) J. Physiol. (submitted). Clark, C.R. et al. (1986). BPS London Meeting, December 1986. Clark, C.R. et al. (1987). J. Med. Chem. (in the press). Hill, R.G. et al. (1987). This meeting. Sharif, N.A. et al. (1986). Biochem. Soc. Trans. 14, 688– 690. Chu, T.G. & Orlowski, M. (1985) Endocrinology 116, 1418. Corbett, A.D. et al (1982) Nature 299, 79. Gillan, M.C.G. et al (1985) J. Neurochem. 45, 1034. Griffiths, E.C. et al (1983) J. Physiol. 343, 117P. Jhamandas, K. et al (1986) Can. J. Physiol. Pharmac. 64, 263. Miller, L. et al (1985) Eur. J. Pharmac. 116, 159. Traynor, J.R. et al (1982) Life Sci. 31, 1377. Ashford, M.L.J. et al (1986) J.Physiol. 381, 116P. Cook, D.L. & Hales, C.N. (1984) Nature 311, 271– 273. Noma, A. (1983) Nature 305, 147– 148. Spruce, A.E. et al (1985) Nature 316, 736– 738. Atterwill et al (1984) Br J Pharmac 83 89– 102. Atterwill et al (1986) Br J Pharmac 88 355P. Fisher & Hanin (1986) Ann Rev Pharmacol Toxicol 26 161– 181. Leventer et al (1985) Neuropharmacol 24 453– 459. Pillar et al (1987) Arch Toxicol, in press. Pillar et al (1987) Br Pharmac Soc, Oxford meeting. Hallcher L. and Sherman W. (1980) J. Biol. Chem. 255, 10896– 10901. Itaya K. and Ui M. (1966) Clinica Chimica Acta 14, 361– 366. Michell R., Cubitt A., Downes C., Hawkins P., King C., Kirk C., Morris A., Mussat M., Shears S. and Storey D. (1986) Hormones and Cell Regulation, Vol. 139 (eds. J. Dumont & J. Nunez) p. 71– 79. Sherman W., Munsell L., Gish B. and Honchar M. (1985) J. Neurochem 44, 798– 807. Storey D., Shears S., Kirk C. and Michell R. (1984) Nature 312, 374– 376. Carswell, H. & Young, J.M. (1986) Br. J. Pharmac. 89, 809– 817. Daum, P.R. et al (1983) Eur. J. Pharmac. 87, 497– 498. Hill, S.J. & Kendall, D.A. (1986) Br. J. Pharmac. 89, 771P. Hollingsworth, E.B. & Daly, J.W. (1985) Biochim. Biophys. Acta 847, 207– 216. Malenka, R.C. & Kocsis, J.D. (1982) J. Neurophysiol. 48, 608– 621. Marwaha, J. et al (1981) Exp. Neurol. 74, 285– 292. Palacios, J.M. et al (1981) Brain Res. 214, 155– 162. Yunger, L.M. et al., (1984) J. Pharmacol. Exp. Ther. 228, 109– 115. Doucet, G. et al (1986) Neuroscience 19, 427. Joyce, J.N. et al (1985) Brain Research 338, 209. Kohler, C. & Radesater, A-C. (1986) Neuroscience Letters 66, 85. Drejer et al. (1986) Life Sci. 38, 2077. Graham et al. (1976) Brain Res. 115, 181. Benavides et al. (1985) Neuropharmacology 24, 1085. Nicoletti et al. (1986) Neuropharmacology 25, 2077. Bradley, P.B. et al. Neuropharmacology (1986) 25 563– 576. Barasi, S. and Roberts, M.H.T. (1974) Br. J. Pharmac. 52 339– 348. Davies, M. et al. (1985a) Br. J. Pharmac. 85 255P. Davies, M. et al. (1985b) Br. J. Pharmac. 86 594P. Davies, M. et al. (1986) Br. J. Pharmac. 89 526P. Lipski, J. (1981) J.Neurosci. meth. 4 1– 32. Curtis, D.R., Phillis, J.W. & Watkins, J.C. (1961) Br. J. Pharmac. 16, 262– 283. Evans, R.H. & Watkins, J.C. (1978) Eur. J. Pharmac. 50, 123– 129. Otsuka, M. & Konishi, S. (1974) Nature 252, 733– 734. Chieuh, C.C. et al (1984) Psychopharmacol. Bull. 20, 548– 553 J.W. Langston (1985) Trends in Neurosci. 8, 79–83. Schneider, J.S. et al (1986) Exp. Neurol. 91, 293– 307. Foster A.C., Gill R., Iversen L.L. and Woodruff G.N. (1986) Br. J. Pharmac. Proc. Suppl. 90: 9P. Wong E.H.F., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N. and Iversen L.L. (1980) Proc. Natl. Acad. Sci. 83: 7104– 7108. Simon R.P., Swan J.H., Griffiths T. and Meldrum B.S. (1984) Science, 226: 850. Smith M.L., Bendek G., Dahlgren N., Rosen I., Wieloch T. and Siesjo B.K. (1984) Acta. Neurol. Scand. 69: 385– 401. Alps, B.J. & Hass, W.K. (1985). Neurology, 35 (suppl 1), 141. Hass, W.K. (1981) In: Cerebral Vascular Disease (eds J.S. Meyer, H. Lechner, M. Reivich, E.O. Ott, A. Aranibar) pp 3– 17, Exerpta Medica, Amsterdam. Siesjo, B.K. (1981) J. Cereb. Blood Flow Metab. 1, 155– 185. Alps, B.J., et al. (1985) Biochem. Soc. Trans., 13 (2), 384. Welch, K.M.A., et al. (1978) Ann. Neurol. 3, 152– 155. Foster, A.C., Grimwood, S. and Kemp, J.A. (1986) Br. J. Pharmac. 89, 869P. Kemp, J.A., Priestley, T. and Woodruff, G.N. (1986) Br. J. Pharmac. 89, 535P. Beauchamp, R.O. Jr. et al. (1984) CRC Crit. Rev. Toxicol. 13: 25– 97. Lindroth, P. and K. Mopper (1979) Anal. Chem. 51, 1667– 1674. Harris, N.C. & Ryall, R.W. (1986) Br. J. Pharmac. 89, 803P. Heapy, C.G., Jamieson, A. & Russell, N.J.W. (1987) Br. J. Pharmac. 90, 164P. Pini, A. & Ryall, R.W. (1986) J. Physiol. 378, 42P. Woolf, C.J. & Wall, P.D. (1986) J. Neuroscience, 6, 1433– 1442. Hellewell, P.G. & Williams, T.J. (1986), J.Immunol. 137, 302– 307. Kravis, T.C. & Zvaifler, N.J. (1974), Int.Arch.Allergy, 46, 60– 71. Williams, T.J., Hellewell, P.G. & Jose, P.J. (1986), Agents Actions, 19, 66– 72. Angus et al. (1986) Br. J. Pharmac. 88, 767– 777. Collins et al. (1986) J. Cardiovasc. Pharmac. 8, 1158– 1162. Griffith et al. (1984) Nature 308, 645– 647. Brittain, R.T. et al. (1985). Circulation 72, 1208– 1218. Bunce, K.T. (1985). Br. J. Pharmac. 86, 815P. Bunce, K.T. & Clayton, N.M. (1985). Br. J. Pharmac. 86, 421P. Spraggs, C.F. & Bunce, K.T. (1985). Gut 26, A1147– A1148. Thulesius, O. & Angelo-Khattar, M. Acta Pharm. et toxicol (1985) 56, 298. Di Rosa, M. et al. Prostaglandins (1984) 28, 441. Collins, P. et al. (1986). J. Physiol. 381, 427– 437. Martin, W. and White, D.G. (1987). Br. J. Pharmacol. Proceedings December 1986 Meeting. Murad, F. et al. (1979). Adv. Cyclic. Nucleotide Res. 11, 175– 204. Rapoport, R.M. (1986). Circ. Res. 58, 407– 410. Rapoport, R.M. and Murad, F. (1983). Circ. Res. 52, 352– 357. Liston, T.E. & Roberts, L.J. (1985) Proc. Natl. Acad. Sci. USA, 82, 6030. Coleman, R.A. et al. (1980a) Br. J. Pharmac. 69, 266P– 267P. Coleman, R.A. et al. (1980b) Br. J. Pharmac. 70, 89– 90P. Coleman, R.A. et al. (1985) Br. J. Pharmac. 85, 273P. Coleman, R.A. et al. (1986) Adv. Prostaglandin Thromboxane Leukotriene Res. (in press). Kennedy, I. et al. (1982) Prostaglandins 24, 667– 689. Moncada, S., et al. (1976) Nature, 263: 663. Furchgott, R.F. & Zawadzki, J.V. (1980) Nature 288: 373. Furchgott, R.F. (1987). In: Mechanisms of Vasodilatation IV, ed. P.M. Vanhoutte, Raven Press, New York, in press. Radomski, M. & Moncada, S. (1983). Thromb. Res. 30: 383. Mellion, B.T. et al. (1981). Blood, 56: 946. Azuma, H., et al. (1985). Br. J. Pharmac. 88, 411. Levi, R., et al. (1976). Fed Proc 35 (8), pp. 1942– 1947. Cameron, J.S. et al. (1983). Circulation 68, 111– 221 (abstr.). Cohen, J. et al. (1979). Br Med J 2, 768. Shaw, R.G. et al. (1980). Med J Aust 2, 629– 630. Harris, A.S. (1950). Circulation 1, 1318– 1328. Conolly, M.E. et al (1971) Br. J. Pharmac. 43, 389– 402. Mazzoni, L. et al (1985) Br. J. Pharmac. 86, 571P. Ney, U.M. (1983) Br. J. Pharmac. 79, 1003– 1009. Downing O.A. et al., (1983) Br. J. Pharmac. 80, 315– 322. Downing O.A. et al., (1986) Br. J. Pharmac. 89, Suppl., 841P. Honda K. et al., (1985) N-S Arch Pharmacol. 328, 264– 272. Limas, C.J. & Limas, C. (1985) Circ. Res. 55: 524– 531. Arunlakshana, O. & Schild, H.O. (1959). Br. J. Pharmacol. 14, 48– 58. Flavahan, N.A. & Vanhoutte, P.M. (1986). Trends Pharmacol. Sci. 7, 347– 349. Furchgott, R.F. (1972). in Handbook of Experimental Pharmacology Vol. 33, Catecholamines: Blaschko, E. Muscholl (ed.), pp 283– 335. Heidelberg, Springer. Holck, M.I. et al. (1983). J. Cardiovasc. Pharmacol. 5, 240– 248. Flavahan, N.A. & Vanhoutte, P.M. (1986) Trends Pharmacol.Sci. 7: 347– 349. Vizi, E.S., Harsing, L.G. Jr., Gaal, J., Kapocsi, J., Bernath, S. J. Pharm.Exp.Ther. (1986) 238, 701– 706. Vizi, E.S., Ludvig, N., Ronai, A.Z., Folly, G. Eur.J.Pharmacol. (1983) 95, 287– 290. Chiodo, L.A. et al (1984) Neuroscience 12, 1– 16. Johnson, R.D. & Justice, J.B. (1983) Brain Res.Bull. 10, 567– 571. Talmaciu, R.K. et al (1986) J.Neurochem. 47, 865– 870. Curtis, B.M. & Catterall, W.A. (1985) P.N.A.S. 82, 2528. Herdon, H. et al (1985) Brain Res. 348, 309. Herdon, H. & Nahorski, S.R. (1987) N.S. Arch.Pharmac. in press. Miller, R.J. (1985) T.I.N.S. 8, 45. Mulder, A.H. & Schoffelmeer, A.N.M. (1985) Adv. Cycclic Nucleotide Res. 19, 273. Spedding, M. & Middlemiss, D.N. (1985) T.I.P.S. 6, 309. Donatsch, P. et al. (1984). Br.J.Pharmac. 81, 34P. Dunbar, A.W., McClelland, C.M. and Sanger, G.J. (1986). Br.J.Pharmac. 88, 319P. McClelland, C.M., McRitchie, B., and Turner D.H. (1983). Br.J.Pharmac. 80, 569P. Sanger, G.J. (1987). Br.J.Pharmac. (in press). Benwell, M.E.M. & Balfour, D.J.K. (1979) Psychopharmacology 63, 7. Benwell, M.E.M. & Balfour, D.J.K. (1982) Eur. J. Pharmac. 84, 71. Middlemiss, D.N. & Fozard, J.R. (1983) Eur. J. Pharmac. 70, 151. Reinhard, J.F. et al (1980) Life Sci. 27, 905. Brittain, R.T., Butler, A. et al. (1987) Br.J.Pharmac. 90, 87P. Costall, B., Domeney, A. et al. (1987) Br.J.Pharmac. 90, 89P. Costall, B., Domeney, A. et al. (1987) Br.J.Pharmac. 90, 243P. Borsini, F. et al (1985). Int. J. Obesity 9, 277– 283. Dourish, C.T. et al (1985). Psychopharmacology 86, 197– 204. Kirkham, T.C. and Cooper, S.J. (1987). Pharmac. Biochem. Behav. in press. Rowland, N.E. and Carlton, J. (1986). Prog. Neurobiol. 27, 13– 62. Smith, C.P. and Gibbs, J. (1979). In: Progress in Psychobiology and Physiological Psychology, vol. 8 ( J.M. Sprague, A.N. Epstein, eds), Academic Press, New York, pp. 179– 242. Weingarten, H.P. and Watson, S.D. (1982). Physiol. Behav. 28, 401– 407. Balster, R.L. (1986). Eur. J. Pharmacol. 127, 283– 286. Largent, B.L. et al. (1986). J. Pharmacol. Exp. Ther. 238, 739– 748. Shannon, H.E. (1983). J. Pharm. Exp. Ther. 225, 144– 152. Tam, S.W., and Cook, L., (1984). Proc. Natl. Acad. Sci. 81, 5618– 5621. Bowery, N.G. et al (1983) Br. J. Pharmac. 78 191– 206. Cross, J.A. & Horton, R.W. (1986) Br. J. Pharmac. 89 521P. Lloyd, K.G. et al (1985) J. Pharmac. Expt. Ther. 235 191– 199. Clow A. et al. (1980) Eur. J. Pharmacol. 63, 135– 144. Gale K. (1980) Nature 283, 569– 570. Quast U. and Brenner O. (1983) J. Neurochem. 41 (2), 418– 425. Bennett, G.W. et al (1983) Br.J.Pharmac. 80, 641P. Chronister, R.B. et al (1982) J.Neurobiol. 13, 23– 37. Kalivas, P.W. (1982) J.Pharmac.Exp.Ther. 222, 37– 42. Prell, G.D. & Green, J.P. (1986) Ann.Rev.Neurosci. 9, 209– 254. Sharp, T. et al (1984) Regulatory Peptides 9, 305– 315. Brazell, M.P. et al (1985) Br. J. Pharmac. 86, 209– 216. Green, A.R. & Youdim, M. (1975) Br. J. Pharmac. 55, 415– 422. Grahame-Smith, D.G. (1971) Br. J. Pharmac. 43, 856– 864. Johnston, J.P. (1968) Biochem. Pharmac. 17, 1285– 1297. Marsden, C.A. et al (1987) Br. J. Pharmac. 90, 85P. Yang, H-Y. & Neff, N.H. (1973) J. Neurochem. 43, 448– 454. Badawy, A. A.-B. (1986) Br. J. Pharmac. 89, 859P. Badawy, A. A.-B. & Evans, M. (1982) Br. J. Pharmac. 77, 59– 67. Randall, J.I. & Rodgers, R.J. (1986) Brit. J. Pharmacol. 89, 797P. Rodgers, R.J. & Randall, J.I. (1987) Psychopharmacology, in press. Bizière, K. et al (1986) Br. J. Pharmac. 87 Suppl.: 21P. Hammer, R. et al. (1980) Nature, 283: 90– 92. Worms, P. et al. (1986) Life Sci. 39: 2199– 2208. Nichols, A.J. & Hiley, C.R. (1985) J.Pharm.Pharmacol. 37, 110– 114. Wilffert, B. et al. (1984) Naunyn-Schmiedberg's Arch. Pharmacol. 328 76– 82. Curtis, M.J. et al., (1984) Br. J. Pharmac. 83, 373– 385. Curtis, M.J. et al., (1985) Europ. J. Pharmac. 117, 169– 178. Curtis, M.J. & Walker, M.J.A. (1986) Brit.J.Pharmac. 89, 137– 147. (Funded by the British Columbia Heart Foundation). Blackburn, T.P. et al., (1986) Br. J. Pharmac. (in press). Kaumann, A.J. et al., (1985) Naunyn-Schmiedeberg's Arch. Pharmacol. 330: R64. Kaumann, A.J. & Frenken, M. (1985) (Ibid) 328, 295– 300. Lemoine, H. & Kaumann, A.J. (1986) (Ibid) 333, 91– 97. Cavero, I., et al. (1987) Fed. Proc. 47, 4368. Harvey, J.N., et al. (1985) Br. J. Clin. Pharmacol. 19, 21. Lokhandwala, M.A. and Barrett, R.J. (1984) J. Aut. Pharmacol. 3, 191. Kurtz, A. et al. (1985) Am. J. Physiol. 250, C563. Kurtz, A. et al. (1986) Proc. Natl. Acad. Sci. 83, 4769. Brown et al (1985a) Br. J. Pharmacol. 85, 599– 608. Brown et al (1985b) Br. J. Pharmacol. 85, 609– 619. Clark et al (1980) J. Pharm. Meth. 3, 357– 368. Dawson et al (1985) Br. Heart J. 54, 313– 320. Pittman, Q.J., Lawrence, D. & McLean, L. (1982) Endocrinology 110, 1058– 1060. Zerbe, R.L. & Feuerstein, G. (1985) Neuropeptides 6, 471– 484. Al-Kazwini, S.J. et al, (1987) Br. J. Pharmac. Proc. Suppl. in press. Craig R. K. et al, (1986) Br. J. Pharmac. 88, Suppl. 312P. References Fuxe, K. et al (1983) Acta. Physiol. Scand. 118, 189– 192. Northover B.J. (1986) Br.J.Pharmac. 8, 141– 148. Rizzon P. & Di Biase M. (1975) Giornale Italiano di Cardiologica 5, 1– 14. Smeets J.L.R.M. et al (1983) New Aspects of the Medical Treatment of Tachyarrhythmias: Role of Amiodarone. Publishers: Urban & Schwarzenberg, Munich, P 19– 30. Arrigoni-Martelli, E. et al (1980) Experientia, 36, 445. Buckingham, R.E. et al (1986) Br. J. Pharmac. 87, 78P. Hamilton, T.C. et al (1986) Br. J. Pharmac. 88, 103. Southerton, J.S. et al (1987) Br. J. Pharmac. Proc. Suppl. 90, 126P. Dart, A.M. et al, (1987). Br. J. Pharmacol. 90, 43– 51. Bradley, P.B. et al. (1986) Neuropharmac. 25, 563– 576. Brittain, R.T. et al. (1987) Br. J. Pharmac. Proc. Suppl. in press. Buchheit, K.H. et al. (1985) Naunyn-Schmiedebergs Arch. Pharmac. 329, 36– 41. Richardson, B.P. & Engel, G. (1986) T.I.N.S. 9 (9) 424– 428. Cascieri, M.A., Chicchi, G.G., Friedinger, R.M., Colton, C. Dylion, Perlow, D.S., Williams, B., Curtis, N.R., McKnight, A.T., Maguire, J.J., Veber, D.F. and Liang, T. (1986). Mol. Pharmac. 29, 34– 38. Fletcher, A.E., McKnight, A.T. and Maguire, J.J. (1987). Br. J. Pharmac. in press. McKnight, A.T. and Maguire, J.J. (1987). Br. J. Pharmac. in press. Wormser, U., Laufer, R., Hart, Y., Chorev, M., Gilon, C. and Selinger, Z. (1986). The EMBO Journal 5, 2805– 2808. Barnes, P.J. (1986) Lancet i, 242. Laitinen, L.A. et al (1986) J. Physiol. 382, 54P. Laitinen, L.A. et al (1987) Br. J. Pharmac. in press. Martling, C-R. et al (1985) Acta Physiol. Scand. 125, 343. BRADFORD, M.M. (1976) Anal.Biochem. 72, 248– 254. COX, H.M. et al. (1986) Br.J.Pharmac. 87, 201– 209. COX, H.M. et al. (1987) Br.J.Pharmac. 90, 393– 401. LEVENS, N.R. et al. (1981) Am.J.Physiol. 240, 617– 624. MANNING, D.C. et al. (1982) Nature (Lond) 299, 256– 259. Brittain, R.T. et al (1985) Circulation, 72. Coleman, R.A. et al (1985) Br.J.Pharmac 85, 273P. Jones, R.L. et al (1982) Br.J.Pharmac. 76, 423– 438. Boyum A. (1968) Scand J Clin Invest, 97 (Suppl) 77– 89. Dayer JM, Beutler, B. and Cerami A. (1985) J Exp Med 162, 2163– 2167. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME and Smith MJH (1980) Nature 286, 264– 265. Pettipher ER, Higgs GA and Henderson B. (1986) Proc Nat Acad Sci 83, 8749– 8753. Pohlman TH, Stanness KA, Beatty PG, Ochs HD and Harlan J. (1986) J Immunol 136, 4548– 4553. Smith MJH and Walker J.R. (1980) Br J Pharmac 69, 473– 478. Bernström K. & Hammerstrom S. (1986) Arch Biochem Biophys 244, No.2, 486– 491. Samhoun MN & Piper PJ (1986) In: The Leukotrienes: their biological significance, Raven Press, New York, pp 151– 160. Dumonde, D.C. and Glynn, L.E. (1962). Brit. J. Exp. Path. 43, 373– 383. Pettipher, E.R., Higgs, G.A. and Henderson, B. (1986). Proc. Natl. Acad. Sci. 83, 8749– 8753. Rosam, A.C., Wallace, J.L. & Whittle, B.J.R. (1986) Nature 319, 54– 56. Whittle, B.J.R. Oren-Wolman, N. & Guth, P.H. (1985) Am. J. Physiol. 248, G580– 586. Blackman, J.G. & McCaig, D.J. (1983). Br. J. Pharmac. 80, 703– 710. Cuthbert, A.W. & Margolius, H.S. (1982) Br. J. Pharmacol. 75, 587– 589. Cuthbert, A.W. et al., (1984) Br. J. Pharmacol. 82, 597– 607. Kubota, K. et al. (1985) Eur. J. Pharmacol. 110, 225– 231. Ordway, G.A. & Longhurst, J.C. (1983) Circ. Res. 52, 26– 35. Hallam, T.J. & Pearson, J.D. (1986a) J. Physiol. 377, 122P. Hallam, T.J. & Pearson, J.D. (1986b) FEBS Letts. 207, 95– 99. Hallam, T.J. & Rink, T.J. (1985) FEBS Letts. 186, 175– 179. Adams, M. et al. (1986) Brit. J. Pharm. 88, 248P. Seamon, K.B. et al. (1984) Proc. Natl. Acad. Sci. (USA) 81, 5081. Behar, J. (1974) Am. J. Physiol. 227 (2), 334– 340. Gunter, T. and Vorman, J. (1985) Bioch. Biophys. res. Comm. 130, 540– 545. Lauterbach, F. (1977) Nauyn-Schmidibergs. Arch. Pharm. 297, 201– 212. Martens, H. (1985) Q. J. Exp. Physiol. 70, 567– 573. O'Donnell, J. M. and Smith, M. W. (1973) J. Physiol. 229, 733– 749. Ross, D. B. (1962) J.Physiol. 160, 417– 428. Merritt, J.E. & Rubin, R.P. (1985) Biochem.J. 230, 151– 159. Peikin, S.R., Rottman, A.J., Batzri, S. & Gardner, J.D. (1978) Am.J.Physiol. 235, 743– 750. Brown MJ, Jenner DA. Clin. Sci. 61: 591– 598, 1981. Bates, R.F.L. et al. (1984) Br. J. Pharmacol. 81, Proc. Suppl., 157P. Bates, R.F.L. et al. (1984) Br. J. Pharmacol. 83, Proc. Suppl., 408P. Aalkjaer, C. et al (1985) Br. J. Pharmac. 86, 447– 453. Faison, E.P. et al (1985) Life Sci. 37, 1073– 1079. Fink, G.D. & Brody, M.J. (1978) Am. J. Physiol. 234 (2), H219– H222. Burdet, R. et al (1986) Br. J. Pharmac. 88, 266P. Byfield, R.A. et al (1986) Br. J. Pharmac. 88, 436P. Carvalho, M.H. & Furchgott, R.F. (1981) Pharmacologist 23, 223. McGregor, D.D. (1965) J. Physiol. (Lond.) 177, 21– 30. Poole, J.C.F. et al (1958) J. Pathol. Bacteriol. 75, 133– 143. Borkowski, K.R. and Kelley, E. (1986) Br. J. Pharmac. 88, 943– 945. U'Prichard, D.C. and Kvetnansky, R. (1979) 2nd Inst. Symp. on Catecholamines and Stress. Czechoslovakia. Yamaguchi, I., Torda, T., Hirata, F. & Kopin, I.J. (1981) Am. J. Physiol. 240, H691– H696. Gallagher, G. Jr., Lavanchy, P.G., Wilson, J.N., Heible, J.P. and DeMarinis, R.M. (1985) 4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: A Prejunctional Dopamine Receptor Agonist. J. Med. Chem, 28, 1533– 1536. Chiu, E.K. (1983). Intern. J. Neuroscience 20, 103– 148. Kobinger, W. & Pichler, L. (1981). Eur. J. Pharmac. 73, 313– 321. Morris, M.J. & Woodcock, E.A. (1982). Clin. Exp. Pharmac. Physiol 9, 303– 307. Pellegrino, L.J. et al (1981). A Stereotaxic Atlas of the Brain. Plenum Press. Pierce, V. & Shepperson, N.B. (1986). Br. J. Pharmac. 88, 285P. Boudier, H.A.J. Struyker et al. (1974). Neuropharmac. 13, 837– 845. Ungerstedt, V. (1971). Acta. Physiol. Scand. S367, 1– 48. Apperley, E., et al. (1976). Br. J. Pharmac. 58, 211– 221. Bowman, A., et al. (1985). T.I.P.S. 6, 284– 285. Furchgott, RF (1983). Circ. Res. 53, 557– 573. Martin, W., et al. (1985). J. Pharmac. Exp. Ther. 232, 708– 716. Tanishima, T. (1980). J. Neurosurg. 53, 787– 793. Verrecchia, C., et al. (1986). Blood Vessels (4th Int. Symposium ‘Mechanism of Vasodilatation’) 23, 106. Drew, GM (1985). Clin Sci, 68, 15s– 19s. De Mey, J. and Vanhoutte, PM (1981). Circ. Res. 48, 875– 884. Shepperson, NB and Langer SZ (1981). N-S Arch. Pharmac. 318, 10– 13. Starke, K. et al. (1975) Ibid, 291, 55– 78. Adcock, J.J. et al, (1986) B.P.S. London Meeting. Follenfant, R.L. et al, (1986) B.P.S. London Meeting. Struyker Boudier HAJ, Bekers AD, (1975) Eur. J. Pharmacol. 31, 153– 155. Flecknell PA, Mitchell M., (1984) Lab. Animals 18, 143– 146. Merlis JK, (1940) Am. J. Physiol. 13, 67– 72. Peres-Polon VL, Correa FMA, (1984) Gen. Pharmacol. 15, 505– 509. Draper AJ, Redfern PH, Roberts J., (1986) Br. J. Pharmac. 88, 454P. Krishnamurty, V.S.R., (1971) Arch. int. Pharmacodyn., 189, 90– 99. McGrath J.C. et al., (1984) J. Physiol., 353, 66P. Dominguez-Mon, M., Ponce-Hornos, J.E., Gómez, R., Cannata, M., & Taquini, A.C. (1984) Meth. and Find. Clin. Pharmac. 6, 373– 378. Hof, R.P. (1986) Br.J.Pharmac. 87, 611– 618. Kruszynski, M., Lammek, B., & Manning, M. (1980) J.Med.Chem. 23, 364– 368. Wilson, M.F., Brackett, D.J., Archer, L.T., & Hinshaw, L.B. (1980) Ann.Surg. 191, 494– 500. Zito, A.R., Diez, A.R., & Groszmann, R.J. (1983) J.Cardiovasc.Pharmac. 5, 586– 591. De Vita, C., et al., Arzneim. Forsch. 36, 349– 354, 1986. English, T.A.H. et al., Br. J. Pharmac. 87, 203P, 1985. Crome R., Hearse, D.J. & Manning, A.S. (1985) Proc.Br.Pharmacol.Soc. C26. Van Gilst, W.H., Graeff, P.A., Wesseling, H. & Langen, D.J. (1986) J.Cardiovasc.Pharmacol. 8, 722– 728. Johnston, K.M., Macleod, B.A. & Walker, M.J.A. (1983) Can.J.Physiol.Pharmacol. 61, 1340– 1353. Alabaster, C.T. and Henderson, C.G., (1982), Br.J.Pharmac. 76, Proc. Suppl. p. 251. Ellis, P., Henderson, C.G., and Samuels, G.M.R. (1987). This meeting. Alabaster, C.T. and Rance, D.J. This meeting. Kukovetz, W.R. et al (1981) in Vasodilatation, Vanhoutte, I. Leusen, Raven Press, New York. Owen, D.A.A. et al (1986) In press Br. J. Pharmac. Armstrong, J.M. et al, (1987) This meeting. Campbell, T.J. (1983) Br.J.Pharmac. 80, 33– 40. Fozzard, H.A. et al, (1986) J.Physiol. in press. Patmore, L. (1982) J.Physiol. 332, 47– 48P. Williams, E.M. Vaughan (1975) Pharmac.Ther.B. 1, 115– 138. Allen J.D., Shanks R.G. and Zaidi (1971) Br.J.Pharmac. 42, 1– 12. Armstrong J.M. and Ferrandon P. (1985) Br.J.Pharmac. 85, 328P. Harris A.S. (1950) Circulation Res. 1, 1318– 1328. Juett J.R. and Patmore L. (1986) This meeting. Manning A.S., Coltart D.J. and Hearse D.J. Circulation Res. 55, 545– 548. Jayakody, R.L. et al, (1986) J. Physiol. 372, 25– 39. Alabaster, V.A. et al., (1984) N-S Arch Pharmacol. 330, 33– 36. Schild, H.O. (1957) Pharmac. Rev. 9, 242– 246. McGrath, J.C. (1982) Biochem Pharmacol. 31, 467– 484. Purdy, J. et al., (1980) Life Sci. 27, 2187– 2195. Furchgott, R.F (1983) Circ. Res. 53, 557– 573. Griffith, T.M. et al. (1984) J. Physiol. (London), 351, 13– 24. Miller, R.C. et al. (1985) Br. J. Pharmac. 84, 20P. Rubanyi, G.M. et al. (1985) Eur. J. Pharmacol. 117, 143– 144. El-Muradi, E.M.A. & McCurrie, J.R. (1985) Br.J.Pharmac. 85, 339P. Gillespie, J.S. and Muir, T.C. (1967) Br.J.Pharmac. Chemother. 30, 78– 87. Bolton, T.B. & Clapp, L.H. (1984). J Physiol. 335: 43. Coldwell, M.C. & Howlett, D.R. (1986). Br J Pharmacol. 88: 443P. Hamilton, T.C., Weir, S.W. & Weston, A.H. (1986). Br J Pharmacol. 88: 103. Smith, J.M. & Jones, A.W. (1985). Circ. Res. 56: 507. Allen S. L. et al (1986). Br J Pharmac. 89: 395– 405. Buckingham, R.E. et al (1986). J Ca
Referência(s)